Status:

RECRUITING

Protons Vs. Photons for High-risk Prostate Cancer

Lead Sponsor:

University of Aarhus

Collaborating Sponsors:

Rigshospitalet, Denmark

Odense University Hospital

Conditions:

Prostate Cancer

Radiotherapy Side Effect

Eligibility:

MALE

18+ years

Phase:

NA

Brief Summary

The purpose of this study is to assess late gastro-intestinal side-effects comparing proton therapy to photon therapy in high-risk prostate cancer patients receiving whole pelvic irradiation.

Detailed Description

Proton therapy (PT) is a radiation technique with possibility to spare normal pelvic organs: bladder, rectum and bowel for PC patients. Most PC patients treated with PT receive PT to the prostate gla...

Eligibility Criteria

Inclusion

  • Histologically verified localized/locally advanced prostate cancer T1-3bN0-1M0 (TNM 8th edition). A clinical T4 is allowed if it is because of invasion into the bladder neck.
  • Adenocarcinoma (mixed histology allowed as long as the adenocarcinoma component comprise more than 50%)
  • Indication for elective lymph node irradiation
  • PSA \< 100 ng/mL
  • Age ≥18 years
  • Performance status 0-1
  • Life expectancy ≥ 10 years
  • Able to understand and comply with the treatment protocol
  • No evidence of inflammatory bowel disease Ability to adhere to procedures for study and follow-up
  • Signed informed consent to participate in the study

Exclusion

  • No previous treatment for prostate cancer
  • Hip-prostheses
  • Other metal devices in the pelvic region (except fiducials)
  • Previous major abdominal/rectal surgery
  • Any other malignancy the last five years except for basal or squamous cell skin cancer
  • Unable to understand patient information or comply with treatment and safety instructions
  • Unable to read and understand patient information due to cognitive disabilities or language (Danish).

Key Trial Info

Start Date :

March 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 1 2037

Estimated Enrollment :

400 Patients enrolled

Trial Details

Trial ID

NCT05350475

Start Date

March 1 2022

End Date

March 1 2037

Last Update

March 7 2025

Active Locations (7)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (7 locations)

1

Dept. of Oncology, Rigshospitalet, Denmark

Copenhagen, Capital Region, Denmark

2

Department of Oncology, Copenhagen University Hospital Herlev

Herlev, Capital Region, Denmark, DK-2730 Herlev

3

Department of Oncology, Aarhus University Hospital

Aarhus, Central Region, Denmark, 8200

4

Dept. of Oncology, Aalborg University Hospital

Aalborg, Region North, Denmark